These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 30509944)

  • 1. The Antibiotic Trimethoprim Displays Strong Mutagenic Synergy with 2-Aminopurine.
    D'Souza S; Miller JE; Ahn J; Subandi R; Lozano D; Ramirez J; Goff M; Davidian C; Miller JH
    Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30509944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring Synergy between Classic Mutagens and Antibiotics To Examine Mechanisms of Synergy and Antibiotic Action.
    Song LY; D'Souza S; Lam K; Kang TM; Yeh P; Miller JH
    Antimicrob Agents Chemother; 2015 Dec; 60(3):1515-20. PubMed ID: 26711761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutagen Synergy: Hypermutability Generated by Specific Pairs of Base Analogs.
    Ang J; Song LY; D'Souza S; Hong IL; Luhar R; Yung M; Miller JH
    J Bacteriol; 2016 Oct; 198(20):2776-83. PubMed ID: 27457718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of the rpoB gene to determine the specificity of base substitution mutations on the Escherichia coli chromosome.
    Garibyan L; Huang T; Kim M; Wolff E; Nguyen A; Nguyen T; Diep A; Hu K; Iverson A; Yang H; Miller JH
    DNA Repair (Amst); 2003 May; 2(5):593-608. PubMed ID: 12713816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Key microstructural mechanisms of the 2-aminopurine mutagenicity: Results of extensive quantum-chemical research.
    Brovarets' OO; Hovorun DM
    J Biomol Struct Dyn; 2019 Jul; 37(10):2716-2732. PubMed ID: 30047849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of 2-aminopurine-stimulated mutagenesis in Escherichia coli.
    Pitsikas P; Patapas JM; Cupples CG
    Mutat Res; 2004 Jun; 550(1-2):25-32. PubMed ID: 15135638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutational specificity of the base analogue, 2-aminopurine, in Escherichia coli.
    Persing DH; McGinty L; Adams CW; Fowler RG
    Mutat Res; 1981 Aug; 83(1):25-37. PubMed ID: 7024792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutagenic and comutagenic effects of ethionine in Escherichia coli K12.
    Zgaga Z
    Mutat Res; 1986 Jul; 174(3):183-7. PubMed ID: 3523235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic interactions of vancomycin with different antibiotics against Escherichia coli: trimethoprim and nitrofurantoin display strong synergies with vancomycin against wild-type E. coli.
    Zhou A; Kang TM; Yuan J; Beppler C; Nguyen C; Mao Z; Nguyen MQ; Yeh P; Miller JH
    Antimicrob Agents Chemother; 2015 Jan; 59(1):276-81. PubMed ID: 25348521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ribonucleoside and deoxyribonucleoside triphosphate pools during 2-aminopurine mutagenesis in T4 mutator-, wild type-, and antimutator-infected Escherichia coli.
    Hopkins RL; Goodman MF
    J Biol Chem; 1985 Jun; 260(11):6618-22. PubMed ID: 3888983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced characterization of the thyA system for mutational analysis in Escherichia coli: Defining mutationally "hot" regions of the gene.
    Mashiach D; Bacasen EM; Singh S; Kao T; Yaramada L; Mishail D; Singh S; Miller JH
    Mutat Res; 2021; 823():111754. PubMed ID: 34091127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutagenicity of the cytidine analog zebularine in Escherichia coli.
    Lee G; Wolff E; Miller JH
    DNA Repair (Amst); 2004 Feb; 3(2):155-61. PubMed ID: 14706349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial Susceptibility and SOS-Dependent Increase in Mutation Frequency Are Impacted by Escherichia coli Topoisomerase I C-Terminal Point Mutation.
    Yang J; Annamalai T; Cheng B; Banda S; Tyagi R; Tse-Dinh YC
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6195-202. PubMed ID: 26248366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutational Consequences of Ciprofloxacin in Escherichia coli.
    Song LY; Goff M; Davidian C; Mao Z; London M; Lam K; Yung M; Miller JH
    Antimicrob Agents Chemother; 2016 Oct; 60(10):6165-72. PubMed ID: 27480851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of recA inactivation on mutagenesis of Escherichia coli exposed to sublethal concentrations of antimicrobials.
    Thi TD; López E; Rodríguez-Rojas A; Rodríguez-Beltrán J; Couce A; Guelfo JR; Castañeda-García A; Blázquez J
    J Antimicrob Chemother; 2011 Mar; 66(3):531-8. PubMed ID: 21212055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutation spectrum induced by dihydropyrazines in Escherichia coli.
    Takechi S; Yamaguchi T; Nomura H; Minematsu T; Adachi M; Kurata H; Kurata R
    Biol Pharm Bull; 2006 Jan; 29(1):17-20. PubMed ID: 16394502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New therapy from old drugs: synergistic bactericidal activity of sulfadiazine with colistin against colistin-resistant bacteria, including plasmid-mediated colistin-resistant mcr-1 isolates.
    Okdah L; Le Page S; Olaitan AO; Dubourg G; Hadjadj L; Rolain JM
    Int J Antimicrob Agents; 2018 May; 51(5):775-783. PubMed ID: 29421171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficiency and extent of mutagenic activity of some new mutagens of base-analogue type.
    Janion C
    Mutat Res; 1978 Jan; 56(3):225-34. PubMed ID: 342940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2-aminopurine induced DNA repair in E. coli.
    Maenhaut-Michel G; Caillet-Fauquet P
    Mol Gen Genet; 1982; 188(1):143-8. PubMed ID: 6217402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2-Aminopurine mutagenesis in Escherichia coli.
    Glickman BW
    Basic Life Sci; 1985; 31():353-79. PubMed ID: 3888180
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.